Broadcast Date: October 6, 2020
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Next Spring marks the tenth anniversary of two key moments in the annals of CRISPR. In San Juan, Puerto Rico, Jennifer Doudna, PhD and Emmanuelle Charpentier, PhD discussed a collaboration that would culminate in an “immortal” paper that repurposed CRISPR-Cas9 into a programmable gene targeting technology. Meanwhile, Feng Zhang heard about CRISPR for the first time, setting him on course to become one of the first investigators to demonstrate genome editing in mammalian cells.

Since the publication of those classic reports in 2012–13, CRISPR has catalyzed a revolution in genome editing, empowering basic researchers around the world, spawning a multibillion-dollar biotech industry, and showing signs of genuine promise in the clinic. But CRISPR has also been misapplied, notably in the creation of “CRISPR babies” in 2018, prompting calls for a moratorium on germline editing.

Kevin Davies, PhD, founding executive editor of The CRISPR Journal, has chronicled these events in his new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing. This GEN keynote webinar takes place on the official publication day of the book. Davies will share highlights and insights from his reporting over the past few years and consider some of the exciting new directions that CRISPR will empower in the years ahead.

 

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

 

About GEN KEYNOTE webinars:

GEN invites renowned experts to lecture on topics of broad interest to the biotechnology and biomedical community. Look for more GEN KEYNOTE webinars in 2020!

 

Produced with support from:

Thermo Fisher logo

Kevin Davies, Phd

Kevin Davies, PhD
Executive Editor, The CRISPR Journal
Author, Editing Humanity: The CRISPR Revolution and the New Era in Genome Editing